Niki BioSolutions, Inc. (NIKI) EBT (2024 - 2025)
Niki BioSolutions' (NIKI) quarterly EBT came in at $328866.0 in Q4 2025, up 424.37% YoY from $62716.4 in Q4 2024, and up 136.01% on a QoQ basis from -$913367.0 in Q3 2025.
Niki BioSolutions, Inc. (NIKI) EBT (2024 - 2025) Analysis & Trends
Niki BioSolutions (NIKI) has 2 years of EBT data on file, last reported at $328866.0 in Q4 2025.
- Quarterly EBT rose 424.37% year-over-year to $328866.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was -$345293.0 (changed N/A YoY) and the FY2025 annual result came in at -$725296.0, down 45.06% from the prior year.
- EBT climbed to $328866.0 in Q4 2025, from -$913367.0 in the prior quarter.
- In the past five years, EBT ranged from a high of $340594.0 in Q2 2025 to a low of -$913367.0 in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | 328,866.00 |
| Aug 31, 2025 | -913,367.00 |
| May 31, 2025 | 340,594.00 |
| Nov 30, 2024 | -101,386.00 |
| Aug 31, 2024 | -170,245.00 |